{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:51:19Z","timestamp":1791273079817,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10067-018-4038-x","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T13:32:01Z","timestamp":1519219921000},"page":"1449-1455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study"],"prefix":"10.1007","volume":"37","author":[{"given":"Fabio Massimo","family":"Perrotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"De Socio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Scriffignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"key":"4038_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038","journal-title":"Lancet"},{"key":"4038_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","volume":"4","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4:130\u2013136","journal-title":"Autoimmun Rev"},{"key":"4038_CR3","first-page":"S295","volume":"18","author":"A Gibofsky","year":"2012","unstructured":"Gibofsky A (2012) Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18:S295\u2013S302","journal-title":"Am J Manag Care"},{"key":"4038_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Comp\u00e1n MV, Oliver S, Schoels M, Scholte-Voshaar M, Stamm T, Stoffer M, Takeuchi T, Aletaha D, Andreu JL, Aringer M, Bergman M, Betteridge N, Bijlsma H, Burkhardt H, Cardiel M, Combe B, Durez P, Fonseca JE, Gibofsky A, Gomez-Reino JJ, Graninger W, Hannonen P, Haraoui B, Kouloumas M, Landewe R, Martin-Mola E, Nash P, Ostergaard M, \u00d6st\u00f6r A, Richards P, Sokka-Isler T, Thorne C, Tzioufas AG, van Vollenhoven R, de Wit M, van der Heijde D (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75:3\u201315","journal-title":"Ann Rheum Dis"},{"key":"4038_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/annrheumdis-2013-204577","volume":"73","author":"JL Nam","year":"2014","unstructured":"Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, Gossec L, Landewe R, Smolen JS, Buch MH (2014) Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 73:516\u2013528","journal-title":"Ann Rheum Dis"},{"key":"4038_CR6","first-page":"2156","volume":"54","author":"TS J\u00f8rgensen","year":"2015","unstructured":"J\u00f8rgensen TS, Kristensen LE, Christensen R, Bliddal H, Lorenzen T, Hansen MS, \u00d8stergaard M, Jensen J, Zanjani L, Laursen T, Butt S, Dam MY, Lindegaard HM, Espesen J, Hendricks O, Kumar P, Kincses A, Larsen LH, Andersen M, N\u00e6ser EK, Jensen DV, Grydeh\u00f8j J, Unger B, Dufour N, S\u00f8rensen V, Vildh\u00f8j S, Hansen IM, Raun J, Krogh NS, Hetland ML (2015) Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry. Rheumatology (Oxford) 54:2156\u20132165","journal-title":"Rheumatology (Oxford)"},{"key":"4038_CR7","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1002\/art.23794","volume":"58","author":"T Sokka","year":"2008","unstructured":"Sokka T, Hetland ML, M\u00e4kinen H, Kautiainen H, H\u00f8rslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimi\u0107 A, Nedovi\u0107 J, Stankovi\u0107 A, Bergman M, Toloza S, Pincus T, Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group (2008) Remission and rheumatoid arthritis. Data on patients receiving usual care in twenty-four countries. Arthritis Rheum 58:2642\u20132651","journal-title":"Arthritis Rheum"},{"key":"4038_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/03009740902932835","volume":"38","author":"B Rintelen","year":"2009","unstructured":"Rintelen B, Sautner J, Haindl PM, Andel I, Maktari A, Leeb BF (2009) Comparison of three rheumatoid arthritis disease activity scores in clinical routine. Scand J Rheumatol 38:336\u2013341","journal-title":"Scand J Rheumatol"},{"key":"4038_CR9","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3899\/jrheum.091131","volume":"37","author":"MH Ma","year":"2010","unstructured":"Ma MH, Scott IC, Kingsley GH, Scott DL (2010) Remission in early rheumatoid arthritis. J Rheumatol 37:1444\u20131453","journal-title":"J Rheumatol"},{"key":"4038_CR10","first-page":"1","volume":"18","author":"M Ishida","year":"2017","unstructured":"Ishida M, Kuroiwa Y, Yoshida E et al (2017) Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review. Mod Rheumatol 18:1\u201324","journal-title":"Mod Rheumatol"},{"key":"4038_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/annrheumdis-2016-209835","volume":"76","author":"LH Tuyl van","year":"2017","unstructured":"van Tuyl LH, Sadlonova M, Hewlett S et al (2017) The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission. Ann Rheum Dis 76:855\u2013861","journal-title":"Ann Rheum Dis"},{"key":"4038_CR12","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/annrheumdis-2013-204798","volume":"74","author":"LH Tuyl van","year":"2015","unstructured":"van Tuyl LH, Hewlett S, Sadlonova M et al (2015) The patient perspective on remission in rheumatoid arthritis: \u2018You\u2019ve got limits, but you\u2019re back to being you again\u2019. Ann Rheum Dis 74:1004\u20131010","journal-title":"Ann Rheum Dis"},{"key":"4038_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348","journal-title":"Arthritis Rheum"},{"key":"4038_CR14","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588","journal-title":"Ann Rheum Dis"},{"key":"4038_CR15","first-page":"123","volume":"11","author":"R Ranza","year":"1993","unstructured":"Ranza R, Marchesoni A, Calori G, Bianchi G, Braga M, Canazza S, Canesi B, Fumagalli M, Mastaglio C, Mathieu A (1993) The Italian version of the functional disability index of the health assessment questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol 11:123\u2013128","journal-title":"Clin Exp Rheumatol"},{"key":"4038_CR16","first-page":"151","volume":"62","author":"J Fransen","year":"2004","unstructured":"Fransen J, Welsing PM, de Keijzer RM, van Riel PL (2004) Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity [abstract]. Ann Rheum Dis 62:151","journal-title":"Ann Rheum Dis"},{"key":"4038_CR17","doi-asserted-by":"publisher","first-page":"R796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletha","year":"2005","unstructured":"Aletha D, Nell VP, Stamm T et al (2005) Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 7:R796\u2013R806","journal-title":"Arthritis Res Ther"},{"key":"4038_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van Riel PL, Tugwell P (2003) A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42:244\u2013257","journal-title":"Rheumatology (Oxford)"},{"key":"4038_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.2011.149765","volume":"70","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LHD, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewe R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M (2011) American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 70:404\u2013413","journal-title":"Ann Rheum Dis"},{"key":"4038_CR20","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Smolen J (2005) The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23:S100\u2013S108","journal-title":"Clin Exp Rheumatol"},{"key":"4038_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1300\/J079v21n04_02","volume":"21","author":"JA Rosenthal","year":"1996","unstructured":"Rosenthal JA (1996) Qualitative descriptors of strength of association and effect size. J Soc Serv Res 21:37\u201359","journal-title":"J Soc Serv Res"},{"key":"4038_CR22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3899\/jrheum.130098","volume":"40","author":"LH Tuyl van","year":"2013","unstructured":"van Tuyl LH, Boers M (2013) Patient-reported remission in rheumatoid arthritis. J Rheumatol 40:350\u2013352","journal-title":"J Rheumatol"},{"key":"4038_CR23","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1002\/art.30524","volume":"63","author":"SH Shahouri","year":"2011","unstructured":"Shahouri SH, Michaud K, Mikuls TR, Caplan L, Shaver TS, Anderson JD, Weidensaul DN, Busch RE, Wang S, Wolfe F (2011) Remission of rheumatoid arthritis in clinical practice: application of the ACR\/EULAR 2011 remission criteria. Arthritis Rheum 63:3204\u20133215","journal-title":"Arthritis Rheum"},{"key":"4038_CR24","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/ar3353","volume":"13","author":"YC Lee","year":"2011","unstructured":"Lee YC, Cui J, Lu B, Frits ML, Iannaccone CK, Shadick NA, Weinblatt ME, Solomon DH (2011) Pain persists in DAS28 rheumatoid arthritis remission but not in ACR\/EULAR remission: a longitudinal observational study. Arthritis Res Ther 13:R83. \n                    https:\/\/doi.org\/10.1186\/ar3353","journal-title":"Arthritis Res Ther"},{"key":"4038_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/annrheumdis-2011-201247","volume":"72","author":"A Kavanaugh","year":"2013","unstructured":"Kavanaugh A, Fleischmann RM, Emery P, Kupper H, Redden L, Guerette B, Santra S, Smolen JS (2013) Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study. Ann Rheum Dis 72:64\u201371","journal-title":"Ann Rheum Dis"},{"key":"4038_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/rheumatology\/kem051","volume":"46","author":"T Sokka","year":"2007","unstructured":"Sokka T, M\u00e4kinen H, Hannonen P, Pincus T (2007) Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology 46:1020\u20131023","journal-title":"Rheumatology"},{"key":"4038_CR27","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/rheumatology\/kes078","volume":"51","author":"YM Punder de","year":"2012","unstructured":"de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL (2012) The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Rheumatology (Oxford) 51:1610\u20131617","journal-title":"Rheumatology (Oxford)"},{"key":"4038_CR28","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1136\/ard.2004.034371","volume":"64","author":"D Heijde van der","year":"2005","unstructured":"van der Heijde D, Klareskog L, Boers M, Landew\u00e9 R, Codreanu C, Bolosiu HD, Pedersen R, Fatenejad S, TEMPO Investigators (2005) Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. Ann Rheum Dis 64:1582\u20131587","journal-title":"Ann Rheum Dis"},{"key":"4038_CR29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/ard.2005.037333","volume":"64","author":"H M\u00e4kinen","year":"2005","unstructured":"M\u00e4kinen H, Kautiainen H, Hannonen P, Sokka T (2005) Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 64:1410\u20131413","journal-title":"Ann Rheum Dis"},{"key":"4038_CR30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/rheumatology\/kem007","volume":"46","author":"M Mierau","year":"2007","unstructured":"Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS (2007) Assessing remission in clinical practice. Rheumatology 46:975\u2013979","journal-title":"Rheumatology"},{"key":"4038_CR31","first-page":"269","volume":"29","author":"ET Molenaar","year":"2002","unstructured":"Molenaar ET, Volkuyl AE, Dijkmans BA (2002) Functional disability in relation to radiological damage and disease activity patients with rheumatoid arthritis in remission. J Rheumatol 29:269\u2013270","journal-title":"J Rheumatol"},{"key":"4038_CR32","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3899\/jrheum.170112","volume":"44","author":"E Lubrano","year":"2017","unstructured":"Lubrano E, De Socio A, Perrotta FM (2017) Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: a cross-sectional analysis of a longitudinal cohort. J Rheumatol 44:1159\u20131164. \n                    https:\/\/doi.org\/10.3899\/jrheum.170112","journal-title":"J Rheumatol"},{"key":"4038_CR33","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3899\/jrheum.150805","volume":"43","author":"FM Perrotta","year":"2016","unstructured":"Perrotta FM, Marchesoni A, Lubrano E (2016) Minimal disease activity and remission in psoriatic arthritis patients treated with anti-TNF-\u03b1 drugs. J Rheumatol 43:350\u2013355","journal-title":"J Rheumatol"},{"issue":"2","key":"4038_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3899\/jrheum.140811","volume":"42","author":"E Lubrano","year":"2015","unstructured":"Lubrano E, Perrotta FM, Marchesoni A, D\u2019Angelo S, Ramonda R, Addimanda O, Olivieri I, Punzi L, Salvarani C (2015) Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-\u03b1 drugs: an Italian multicenter study. J Rheumatol 42(2):258\u2013263","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4038-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4038-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4038-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:41:41Z","timestamp":1550709701000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4038-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4038-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,21]]},"assertion":[{"value":"27 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The subject\u2019s written consent was obtained according to the Declaration of Helsinki and the study was approved by the scientific committee of our institution.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All patients enrolled in the study signed informed consent. The study was performed in a setting of clinical practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}